A method to study the function of individual African swine fever virus (ASFV) gene products utilizing the Escherichia coli lac repressor-operator system has been developed. Recombinant viruses containing both the lacI gene encoding the lac repressor and a strong virus late promoter modified by the insertion of one or two copies of the lac operator sequence at various positions were constructed. The ability of each modified promoter to regulate expression of the firefly luciferase gene was assayed in the presence and in the absence of the inducer isopropyl ␤-D-thiogalactoside (IPTG). Induction and repression of gene activity were dependent on the position(s) of the operator(s) with respect to the promoter and on the number of operators inserted. The ability of this system to regulate the expression of ASFV genes was analyzed by constructing a recombinant virus inducibly expressing the major capsid protein p72. Electron microscopy analysis revealed that under nonpermissive conditions, electron-dense membrane-like structures accumulated in the viral factories and capsid formation was inhibited. Induction of p72 expression allowed the progressive building of the capsid on these structures, leading to assembly of ASFV particles. The results of this report demonstrate that the transferred inducible expression system is a powerful tool for analyzing the function of ASFV genes.
African swine fever virus (ASFV), the only known member of the genus "African swine fever-like viruses" (25) , is the causative agent of a severe disease of swine. Besides its ability to infect different species of suids, ASFV infects soft ticks of the Ornithodoros genus (56, 58) , which act as vectors for the virus propagation. The viral genome is a single molecule of double-stranded DNA ranging in size from 170 to 190 kbp, depending on the virus strain (9) . The analysis of the complete nucleotide sequence of the avirulent isolate BA71V has revealed the existence of 151 putative genes (61) . The virus encodes enzymes involved in DNA replication, gene transcription, and protein modification, as well as proteins that may modulate the host immune response against infection. The functions of some of these proteins have been analyzed (61) , and the coding sequences for 12 structural proteins have been reported (17, 39, 51, 52, 61) . However, the functions of most of the virus-encoded proteins are unknown. The virus particle, which shows a morphology very similar to that of iridoviruses (15) , has a diameter of about 200 nm and comprises several concentric domains. The central structure is the viral core, which is composed of a DNA-containing nucleoid surrounded by a thick protein layer, the core shell. The viral core is wrapped by a lipid envelope and an icosahedral capsid (4, 15) . Extracellular ASFV particles usually possess an additional membrane acquired by budding through the plasma membrane (11) .
In an attempt to facilitate the analysis of the role of individual ASFV genes, we have developed a system for inducible gene expression from ASFV recombinants. In a previous report, we showed that the ASFV genome can be genetically manipulated by homologous recombination (45) . Recombinant viruses can be selected by following the expression of either the Escherichia coli lacZ gene, which encodes ␤-galactosidase (␤-Gal) (45) , or the E. coli gusA gene, which encodes ␤-glucuronidase (GUS) (28) . Both markers enable ASFV recombinants with multiple genetic modifications to be obtained (42) . By using this approach, we have inserted into the ASFV genome an inducible expression system based on the E. coli lac operon. This allows the expression of genes to be conditionally, temporally, and quantitatively regulated, either individually or in combination with other genes.
Enzymes encoded within the lac operon are under the negative control of a repressor which can bind specifically and with high affinity to a sequence of 21 bp representing the functional core of the operator sequence, known as O 1 (8) . The lac repressor can also bind to allolactose or to nonmetabolizable derivatives, such as isopropyl ␤-D-thiogalactoside (IPTG), which decrease the affinity of the repressor for the operator. In this manner, IPTG can diminish the repression of lac operon transcription, resulting in an induction of expression. The system has been well characterized and can regulate the expression of transfected and integrated reporter genes in mammalian cells (for a review, see reference 30) . This system has also been used to regulate gene expression in cells infected with recombinant vaccinia virus (1, 27, 43) , constituting a powerful tool for the analysis of virus morphogenesis (47) , transcriptional regulation (62) , and virus-host cell interactions (36) .
The utility of the system described below is shown by the inducible expression of foreign firefly luciferase (24) and the ASFV major capsid protein p72 (37) . A recombinant virus which inducibly expresses the protein p72 (vA72) was absolutely dependent on the addition of the inducer for production of infectious virus. Electron microscopic analysis of vA72-infected cell factories showed that induction of p72 synthesis leads to progressive formation of the capsid on the external surfaces of previously accumulated electron-dense membranous structures. These viral membranes become polyhedral structures which evolve toward the generation of virus particles.
MATERIALS AND METHODS

Cells and viruses.
Vero cells were grown in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum. The ASFV strain BA71V was propagated and titrated as previously described (26) . Virus infections were carried out with DMEM containing 2% fetal bovine serum. Recombinant virus vA72 was grown in the presence of 1.25 mM IPTG.
Antibodies. The monoclonal antibodies 17L.D3 and 19B.A2, and the rat serum against protein p72, have been described previously (14, 29, 48) . The rabbit polyclonal anti-p37/p14 serum, which also recognizes the precursor form pp220, has been described before (50) . The secondary antibodies for immunoelectron microscopy, rabbit anti-mouse immunoglobulin G (IgG) and IgM and goat anti-rat Ig, were obtained from Dako and Nordic, respectively.
Plasmid construction. (i) pU104GUSREP. A 122-bp DNA fragment containing the promoter sequence of the early ASFV gene U104L (2) was generated by PCR using the primers 5Ј-GCGCGAATTCGTCGACGGATTTTAATTAGAT TTGTGA and 5Ј-GCGCTCTAGATGTAGTGTTATATTACGAAAA, which contain EcoRI and XbaI restriction endonuclease sites at their 5Ј ends, respectively. The PCR product was digested with EcoRI and XbaI and was cloned into EcoRI-XbaI-digested pUC119 to generate the plasmid p119pU104. A 398-bp DNA fragment containing the 5Ј end of the lacI gene of E. coli was obtained by PCR from the pRSV-1 plasmid (32), by using the primers 5Ј-CGCGAAGCTT CTAGATGAAACCAGTAACGTTATACG and 5Ј-CCAGCGGATAGTTAAT GATCAGC (the former contains HindIII and XbaI sites at the 5Ј end). The synthetic PCR fragment was cut with HindIII and MluI and was cloned into pRSV-1 digested with HindIII and MluI to generate pREP. A 1.2-kb XbaI fragment from pREP containing the complete lacI coding sequence was cloned into p119pU104 digested with XbaI, generating the plasmid pU104REP. Plasmid pU104REP10T was obtained by cloning a Klenow enzyme-treated 1.3-kb SalI fragment from pU104REP into p119.10T (28) digested with SmaI. A 1.3-kb SalI/EcoRI/Klenow enzyme-treated fragment from pU104REP10T was cloned into SmaI-digested pINSGUS (28) , producing the transfer vector pU104GUSREP10T. pINSGUS contains BA71V EcoRI fragment sequences, including the nonessential coding sequence of the thymidine kinase (TK) gene, which had previously been used as a locus for the insertion of foreign genes.
(ii) pRG, pRG.I, pRG.II, pRG.*I, and pRG.*II. A DNA fragment containing the core sequence of the E. coli lac operator O 1 was generated by annealing the partially overlapping oligonucleotides 5Ј-GATCTAATTGTGAGCGGATAAC AATTG and 5Ј-GATCCAATTGTTATCCGCTCACAATTA (the core sequence of the lac operator is underlined). The resultant hybrid contains one end compatible with BamHI, so that the cloning of one or more copies of the fragment into a BamHI site results in the retention of a single BamHI site in the derivative plasmid. After annealing, the DNA fragment was incubated with T4 polynucleotide kinase and ATP and was ligated into the plasmid p72.4 (28) digested with BamHI. Two plasmids, p72.I and p72.II, containing one and two copies, respectively, of the operator sequence downstream of the viral late p72.4 promoter and upstream of a unique BamHI site, were selected. A 118-bp PCR DNA fragment containing the p72.4 promoter and the core sequence of the operator was generated from the p72.4 plasmid by using the oligonucleotides 5Ј-CGCGAGATCTTTGTTATTATCAAGATCC and 5Ј-GCGCGGATCCAA TTGTTATCCGCTCACAATTTATATAATGTTATAAAAATAATTT, which contain, respectively, the restriction sites BglII and BamHI at their 5Ј ends. The PCR product was digested with BamHI and BglII and was then inserted into BamHI-linearized pUC118 to generate the plasmid p72.*I. By following the procedure used to generate p72.I, a second copy of the operator was inserted into the BamHI site of p72.*I to obtain the plasmid p72.*II. A 1.4-kb fragment containing the Photinus pyralis luciferase gene (24) was extracted from pKLuc and cloned into the BamHI sites of plasmids p72.4, p72.I, p72.II, p72.*I, and p72.*II, generating, respectively, p72.4.luc, p72.I.luc, p72.II.luc, p72.*I.luc, and p72.*II.luc. A 3.3-kb XbaI/Klenow enzyme-treated fragment from pINS72-␤gal (45) , which contains the chimeric gene p72-lacZ (p72 promoter and lacZ gene), was cloned into p72.4.luc, p72.I.luc, p72.II.luc, p72.*I.luc, and p72.*II.luc linearized with SalI and 3Ј-end filled with Klenow enzyme to generate, respectively, pUCgal.luc, pUCgal.luc.I, pUCgal.luc.II, pUCgal.luc.*I, and pUCgal.luc.*II. Transfer vectors pRG, pRG.I, pRG.II, pRG.*I, and pRG.*II were generated by inserting 5.2-kb HindIII/Klenow enzyme/SmaI-treated fragments from pUCgal .luc, pUCgal.luc.I, pUCgal.luc.II, pUCgal.luc.*I, and pUCgal.luc.*II, respectively, into pEЈ(HdA) linearized with EcoRV. pEЈ(HdA) was obtained by inserting a HindIII-to-AccI fragment of the EcoRI EЈ fragment of BA71V DNA into HindIII/AccI-digested pUC119. This fragment contains the CD2 coding sequence, which has previously been used as a locus for insertion of foreign sequences in ASFV recombinants (46) .
(iii) pINDp72.I.␤gal(d) and pINDp72.I.␤gal(i). A synthetic DNA fragment of 427 bp, which contains the nucleotide sequence from Ϫ513 to Ϫ111 relative to the translation initiation codon of the ASFV B646L gene encoding the protein p72, was obtained by PCR from purified virus DNA by using the primers 5Ј-C GCGAATTCTTTATTTATCTTTTAC and 5Ј-CGCGAGATCTTAATTAACG ATCAGC (these primers include EcoRI and BglII restriction sites at their respective 5Ј ends). pFl1 was generated by inserting this PCR fragment, cut with EcoRI and BglII, into BamHI/EcoRI-treated pUC118. The oligonucleotides 5Ј-CGCGGATCCATGGCATCAGGAGGAG and 5Ј-CGCGAGATCTAGCT GACCATGGGCC were used as primers to obtain a 422-bp PCR DNA fragment corresponding to the 5Ј end (400 bp) of the B646L coding sequence (the primers include, respectively, BamHI and BglII restriction sites at their 5Ј ends). The PCR fragment was digested with BglII and BamHI and inserted into BamHIlinearized p72.I, producing the plasmid pFl2-p72.I. A 524-bp SmaI-to-XbaI fragment treated with Klenow enzyme from pFl2-p72.I was cloned into pFl1 digested with HindIII and treated with Klenow enzyme, producing the plasmid pINDp72.I. A 3.3-kb fragment obtained by digestion with SmaI and SalI endonucleases and treatment with Klenow enzyme from p72GAL10T (28) was cloned into SalI-linearized and Klenow enzyme-treated pINDp72.I, producing the transfer vectors pINDp72.I.␤gal(d) and pINDp72.I.␤gal(i), where the p72-lacZ chimeric gene was inserted in the same or in the opposite transcriptional orientation as the B646L gene, respectively.
Generation of recombinant viruses. Recombinant viruses were generated as previously described (45) . The structures of all the recombinant viruses described in this report were confirmed by DNA hybridization analysis (data not shown). The runs of seven or more consecutive thymidylate (T) residues in the coding strand are signals for mRNA 3Ј-end formation (2, 3) . Thus, to minimize the risk of causing transcriptional disturbances when inserting chimeric genes into the virus genome, signals for the 3Ј-end formation of ASFV mRNAs were placed in transfer vectors. The positions of these signals in the viral genome of ASFV recombinants generated in this report are indicated in Fig. 1 , 2A, and 3A.
(i) vGUSREP. Transfer vector pU104GUSREP10T, which contains a copy of the E. coli lacI gene under the control of the early virus promoter pU104 and the chimeric gene p72.4-gusA flanked by BA71V TK DNA sequences, was used to insert the lacI gene into the virus genome. Vero cells were infected with the BA71V strain of ASFV and transfected with pU104GUSREP10T. At 48 h postinfection (hpi), cells were harvested and diluted samples were used to infect Vero cell monolayers. The infected cells were covered with agar, and 4 days later, the GUS substrate 5-bromo-4-chloro-3-indolyl-␤-D-glucuronic acid (X-Gluc) was added to the culture medium. The blue-stained recombinant plaques were selected and used to infect fresh monolayers of Vero cells. In this way, the recombinant virus vGUSREP was purified by three successive rounds of plaque isolation.
(ii) vA2, vA3, vA4, vA5, and vA6. Transfer vectors pRG, pRG.I, pRG.II, pRG.*I, and pRG.*II, containing different p72.4 promoter-operator-luciferase chimeric genes and the gene cassette p72-lacZ, flanked by BA71V CD2 DNA sequences, were used to obtain the recombinant viruses vA2, vA3, vA4, vA5, and vA6, respectively, from the recombinant virus vGUSREP. These recombinants were obtained in a similar way as vGUSREP, but the ␤-Gal substrate X-Gal (5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside) was used for the selection of the blue-stained recombinant plaques.
(iii) vA72. Transfer vectors pINDp72.I.␤gal(d) and pINDp72.I.␤gal(i) were used to generate the vA72 recombinant, in which an operator sequence was inserted between the p72 promoter and the B646L gene, which encodes the protein p72. They contain the gene cassette p72-lacZ and the operator sequence placed 8 bp downstream of the transcription initiation site of the p72.4 promoter. These sequences were flanked by the nucleotide sequence from Ϫ513 to Ϫ111 relative to the translation start codon of the B646L gene and a 400-bp sequence corresponding to the 5Ј end of the gene. All the purification steps were carried out in the presence of 1.25 mM IPTG, and the vA72 recombinant was obtained from transfer vector pINDp72.I.␤gal(i).
Luciferase assay. Vero cell monolayers cultured in 24-well plates were infected at 20 PFU per cell in the presence or in the absence of IPTG. Infected cells were harvested 24 hpi and were processed for luciferase activity determination as previously described (28) . Protein levels were determined as described elsewhere (10) .
Metabolic labeling and immunoprecipitation analysis. Vero cell cultures were infected at 5 PFU per cell and pulse-labeled for 1 h with [
35 S]methionine at 16 hpi in methionine-free medium. The radioactive samples were dissociated and immunoprecipitated with the corresponding antibodies and protein A-coated Sepharose (31) . For the electrophoretic analysis, whole extracts or immune complexes were solubilized by boiling in Laemmli sample buffer (0.05 M TrisHCl [pH 6.8], 2% sodium dodecyl sulfate (SDS), 0.1 M dithiothreitol, 10% glycerol) and were analyzed by SDS-polyacrylamide gel electrophoresis (PAGE) (7 to 20% polyacrylamide) as previously described (34) . Radioactive proteins were detected by fluorography (35) .
Electron microscopy. For Epon embedding and postembedding immunolabeling, infected Vero cells were detached from the tissue culture dish at the indicated times by treatment with proteinase K (50 g/ml) on ice for 2 to 3 min. For conventional Epon embedding, cells were fixed with 2% glutaraldehyde and 2% tannic acid in phosphate-buffered saline at room temperature for 1 h. Postfixing was carried out with 1% OsO 4 in phosphate-buffered saline at 4°C for 30 min. For postembedding immunolabeling, cells were fixed with 8% paraformaldehyde at 4°C for 1 h and processed for Lowicryl embedding as described elsewhere (12) . Immunogold labeling was performed as previously described (4) with a rat serum against p72, a goat anti-rat Ig, and protein A-gold complexes (15 nm; BioCell Research Laboratories, Cardiff, United Kingdom).
For preembedding immunolabeling, cells were processed as previously described (53) . In general, Vero cells were permeabilized with 4 U of the bacterial toxin streptolysin O (Sigma)/ml and fixed with 4% paraformaldehyde for 5 min on ice. Cells were sequentially incubated with a rat serum against p72 or a mixture of monoclonal antibodies (17L.D3 and 19B.A2), anti-p72 (48) , and protein A-gold complexes (5 nm), and were postfixed in 1% glutaraldehyde. Finally, cells were stained with 1% OsO 4 -1.5% K 3 Fe(CN) 6 for 60 min, followed by 1% magnesium uranyl acetate for 60 min, and were processed for conventional Epon embedding.
Specimens were viewed with a JEOL 1010 or a JEOL 1200ϫ electron microscope.
RESULTS
Generation of an ASFV recombinant expressing the lac repressor protein. In order to incorporate into ASFV the inducible expression system based on the E. coli lac operon, we first generated a recombinant virus expressing the lac repressor protein. This virus was obtained by cloning the lacI gene into a transfer vector downstream of the promoter of the ASFV U104L early gene (2) . The resulting virus, vGUSREP, possesses the genomic structure shown in Fig. 1 , where the coding sequences of lacI and a reporter gene, gusA, are inserted into the nonessential TK gene (45) of the virus strain BA71V. The gusA gene, which encodes GUS, allowed for the selection and purification of vGUSREP by blue staining of the recombinant plaques with the enzyme substrate X-Gluc as previously shown (28) . The presence of functional repressor protein in vGUSREP-infected cells was confirmed by gel retardation analysis of a radiolabeled DNA fragment containing the core 21-bp operator O 1 sequence (data not shown).
Generation of vGUSREP-derived recombinant viruses with hybrid virus promoters containing the lac operator sequence. To test if the repressor protein was able to control the gene expression from ASFV recombinants, we generated different hybrid virus promoters by fusing the operator sequence to a virus late promoter. One or two copies of the operator O 1 were placed at different locations between the strong promoter p72. 4 (28) and the coding sequence of the firefly luciferase gene. This would permit us to ascertain the influence of the position of the operator relative to the promoter and of the number of operators on the degree of the repression and induction of gene activity. Another construct, lacking the operator, was generated as a positive control of the p72.4 promoter activity. All these chimeric genes (a general scheme is shown in Fig. 2B ) were inserted into the nonessential region corresponding to the CD2 gene (46) . DNA hybridization and PCR analysis were carried out to confirm the genomic structures of the recombinant viruses thus obtained, vA2, vA3, vA4, vA5, and vA6 (data not shown). The genomic structure of vA3, which is generally applicable for all of these, is shown in Fig.  2A .
Vero cells were infected with the recombinants described above at 20 PFU per cell, and the luciferase activity was determined at 24 hpi in the presence or absence of IPTG (Fig.  2B) . The spacing between the operator and the transcription initiation site was found to be important for the level of repression. Distances of 8 (vA3) or 2 (vA5) bp resulted in ex- In each experiment all infections were carried out in duplicate, and luciferase assays on each sample were carried out in duplicate. The values were adjusted to total protein content. pression levels of 6 and 1%, respectively. The presence of a second operator reinforced the tightness of repression. Two tandem operators located 8 (vA4) or 2 (vA6) bp from the RNA start site allowed levels of luciferase activity less than 0.4% of the control level. The level of IPTG-induced luciferase expression is also dependent on the number of the operators and on their location. Thus, the gene activity in cells infected with viruses containing one operator placed at 8 (vA4) or 2 (vA5) bp reached values of 75 and 37%, respectively. On the other hand, the activity in cells infected with viruses containing tandem operators was only about 6%. Similar induction/repression rates of luciferase expression were obtained for all recombinants at different multiplicities of infection (MOI) (0.1 to 20 PFU per cell) (data not shown).
The effect of IPTG concentration on induction of luciferase expression was studied in cells infected with recombinant viruses vA3 and vA5. A stepwise increase of the IPTG concentration in the medium up to 1.25 mM gradually increased the gene activity (Fig. 2C) . Thus, the transferred inducible expression system will allow the quantitative regulation of expression for a target gene. Moreover, maximum levels of gene activity were obtained with an IPTG concentration of 1.25 mM, which has no effect on infectious virus yield or on plaque formation (see below).
Construction of an ASFV recombinant inducibly expressing the p72 structural protein. An application of the lac operatorrepressor system described above would be the study of the function of ASFV genes through their conditional expression. To test this, we inducibly expressed the B646L gene, which encodes the major capsid protein p72 (18, 37) . For this purpose, an operator was inserted between the gene and its promoter into the vGUSREP genome. Since p72 is a major structural protein (13, 57) expressed during the late phase of the infection cycle, we constructed transfer vectors allowing high levels of gene induction. To this end, and based on the results described above (Fig. 2B) , we inserted the operator sequence 8 bp downstream from the transcriptional start point in the recombinant vGUSREP. The purification of the resulting recombinant virus was carried out in the presence of IPTG in order to allow the expression of p72 in the presence of the repressor. Thus, the recombinant virus vA72 was obtained by using the transfer plasmid pINDp72.I.␤gal(i) (Fig. 3A) . In this construct, the chimeric gene p72-lacZ is inserted in the transcriptional orientation opposite that of the B646L gene.
vA72 is an IPTG-dependent recombinant virus. The ability of recombinant virus vA72 to form plaques under repression or induction conditions was studied. Plaques obtained on vA72-infected cells in the presence of IPTG were smaller than those obtained after infection with the parental BA71V virus (Fig.  3B ). This result was not due to toxicity of the inducer, which at 1.25 mM had no effect on plaque formation by the parental virus (Fig. 3B ), but to an incomplete induction of the protein p72 (see below). The number of plaques formed in the absence of the inducer was strongly reduced (40-to 50-fold). One-step virus growth curves of vA72 showed that the virus titers do not increase over time in the absence of IPTG, remaining about 3 log units below the titers obtained with the parental virus, BA71V (Fig. 3C) . Under permissive conditions, the infectious virus yield of vA72 increased during the infection, but the maximal levels observed were lower, by 0.5 log units, than those found after BA71V infections. We have also tested the ability of vA72-infected cells maintained for different times under nonpermissive conditions to produce infectious virus after the addition of inducer. As shown in Fig. 3C , virus titers increased sharply after the addition of inducer at 16 hpi. When the inducer was added later, virus production increased more slowly. Interestingly, the later the time of IPTG addition, the lower the final virus yield obtained, indicating that restoration of infectivity depends on the time of p72 induction.
Synthesis of the protein p72 is IPTG-dependent. To test whether the expression of protein p72 was dependent on the presence of IPTG, we labeled infected cells with protein band with an electrophoretic mobility of about 115 kDa, representing the ␤-Gal enzyme, was present on vA72-infected cells (Fig. 4A) . Since GUS protein comigrates with protein p72, it was not possible to discern in this assay the effect of IPTG on the induction of p72.
Therefore, to analyze the expression of p72, cell lysates were immunoprecipitated with a p72-specific antibody. As shown in Fig. 4B , a strong reduction of p72 levels was observed in the absence of the inducer. A densitometric quantification of the autoradiography showed that p72 expression in cells infected with vA72 in the absence and in the presence of IPTG was 5 and 60%, respectively, of that obtained in cells infected with the parental virus, BA71V. Immunoprecipitation with a serum against the ASFV polyprotein pp220 (50) was used as an internal control to verify that equivalent amounts of extract had been analyzed.
Effect of p72 repression on virus morphogenesis.
To analyze the effect of p72 repression on ASFV assembly, we performed electron microscopy studies of infected cells. In general, the virus-induced structures observed in vA72-infected cells in the presence of IPTG (Fig. 5A) were similar to those found in parental BA71V-infected cells (4) (5) (6) . Assembling virions and irregular and parallel arrangements of membrane-like structures were observed in the replication areas. A recent report has shown that ASFV particles assemble from these viral membranes, which become polyhedral structures after capsid formation on their convex surfaces (4) . Interestingly, the analysis of vA72-infected cells in the absence of the inducer showed no production of polyhedral viral structures but a strong accumulation of unusual membranous structures (Fig. 5B) . These structures, which have been referred to as "zipper-like" (5, 6), consist of one pair of parallel and extended viral envelopes bound by a thick protein layer structurally similar to the core shell of the virus particle (4) (Fig. 5B) . A close inspection revealed two types of zipper-like structures. One of them, referred to as "single," is formed by a copy of the core shell (Fig. 5B, insert a) , while a second one, referred to as "double," is composed of two copies (Fig. 5B, insert b) . Altogether, both zipper-like structures represent a minor proportion of the virus structures induced in the replication areas of parental BA71V-(5, 6) or vA72-infected cells under permissive conditions (Fig.  5A) . However, while the single structures were frequently detected (Fig. 5A) , the double structures were rarely seen.
Effect of p72 expression on virus morphogenesis. To examine the effect of p72 expression on the structures seen in the replication areas constituted under nonpermissive conditions, we analyzed vA72-infected cells maintained during 16 h in the absence of the inducer and then incubated for different periods with IPTG. Major ultrastructural changes were observed in the assembly sites from 4 h postinduction onward ( Fig. 5C and 6 ). Expression of p72 led to the formation of polyhedral structures from the previously accumulated membranous structures either on single (Fig. 6A) and double (Fig. 6B) zipper-like structures or on normal viral envelopes (Fig. 6C) . A high-magnification analysis revealed that this transformation was concomitant with the appearance of a new layer about 7 nm thick on the external surfaces of the membrane-like structures (Fig. 6) . We conclude that this layer corresponds to the viral capsid, as deduced by the regular array of subunits composing it (Fig. 6A 2 ) as well as by its effect on the virus shape.
Interestingly, capsid formation gave rise to different assembling virions depending on the type of precursor membranous structures. Thus, typical polyhedral virions were assembled from normal viral membranes (Fig. 7A) . On the other hand, capsid formation on double zipper-like structures seemed to lead to separation between the two copies of the core shell, thus resulting in the assembly of apparently normal particles (Fig. 7B ). These observations are in good accordance with the restoration of vA72 infectivity observed after the addition of the inducer at 16 hpi (Fig. 3C) . Finally, capsid formation on single zipper-like structures led to the generation of a subpopulation of assembling virions morphologically distinct from normal particles. This type of intermediate form, rarely observed in infections with normal ASFV, incorporated two membrane envelopes encompassing the core shell ( Fig. 7C and  E) . These double-enveloped particles likely represent aberrant forms of ASFV. However, we cannot discard the possibility that these viral forms eventually evolve to normal virus by segregation of the innermost envelope, as is suggested in Fig.  7C 2 . Additionally, we detected double-enveloped virions with an electron-dense nucleoid (Fig. 7D) . Whether this nucleoid has a composition identical to that of normal virus particles remains to be answered.
To verify that capsid formation was a consequence of p72 expression, we performed immunogold labeling on ultrathin sections of vA72-infected cells with specific antibodies. Viral factories of cells infected for 16 hpi in the absence of inducer were poorly labeled (Fig. 8A 1 ) . In contrast, in infected cells induced for a 8-h period beginning at 16 hpi, strong labeling was detected in the replication areas (Fig. 8A 2 ) on zipper-like structures and polyhedral virus particles.
Ultrastructural localization of p72 in the virus particle. Recently, Cobbold et al. (19) have proposed that p72 is externally and internally located in the intracellular virus particles, pe- ripherally bound to both surfaces of the viral envelope. However, the ultrastructural studies described in the present report clearly indicate that the capsid is built exclusively on the outer surface of the viral envelope. To analyze this apparent contradiction, the precise localization of p72 in the virus structure was determined by preembedding labeling experiments with infected cells permeabilized with streptolysin O (as described in Materials and Methods). For this purpose, we infected Vero cells with either the parental virus, BA71V, or recombinant vA72 virus under permissive conditions.
As shown in Fig. 8B for the parental virus, gold particles strongly decorated the external layers, i.e., the capsids, of the intracellular virions and "open" virus structures (Fig. 8B 1 and  B 2 ). Interestingly, labeling was virtually absent from the inner side of the envelope in these open particles. Moreover, most of the labeling associated with the precursor viral envelopes was located only on one of their two faces (Fig. 8B 3 ) , probably the side on which the capsid would be assembled. A similar labeling pattern was obtained with the recombinant vA72 virus (data not shown).
These results, together with the ultrastructural analysis of recombinant vA72-infected cells, argue in favor of an exclusively external location of p72 in the intracellular virus particles.
DISCUSSION
Inducible expression of genes from ASFV recombinants. A system for the inducible expression of genes from ASFV recombinants is presented. This system is based on the binding of the E. coli lac repressor protein to the operator sequence of an inducible promoter and has been previously transferred successfully to regulate the expression of transfected or integrated reporter genes in mammalian cells (for a review, see reference 30) and vaccinia virus-infected cells (1, 27, 36, 43, 47, 62) .
The E. coli lacI gene, encoding the repressor protein, was inserted into the virus genome of the ASFV strain BA71V under the transcriptional control of the promoter of the virus early gene U104L, generating the recombinant virus vGUSREP. Gel retardation analysis showed that the repressor was present late in infection and thus was available for regulating any virus late promoter containing the operator se- binant vA2 lacking the operator. This reduced induction could be due to the presence of the palindromic operator sequence, which can reduce the translatability of mRNA because of its ability to form hairpin structures (33) . A similar mechanism would explain the strong decrease of activity in vA4 and vA6 in the presence of IPTG, where the combined effects of two tandem operators can further reduce mRNA translation. On the other hand, the repression of the different constructs ranged between 94 and Ͼ99% of the total activity. Previously, it has been reported that the repressor-operator interaction blocks either RNA polymerase transcription initiation in E. coli (55) or transcriptional elongation by E. coli RNA polymerase (21) and eukaryotic RNA polymerase II (22) . Whether the repression effect in ASFV recombinants is due to blocking of transcriptional initiation and/or polymerase elongation remains to be ascertained.
As shown in Fig. 2C , the inducer concentration would allow the expression of the analyzed gene to be adjusted to defined levels. This possibility will further our understanding of the function of ASFV proteins under the control of this inducible system, since the amount of target protein expressed can define the phenotype of the mutant virus.
The system described may be a useful and easy way to study the precise function of structural proteins during ASFV morphogenesis.
Role of the major capsid protein p72. This report shows, by analysis of the B646L gene, which encodes the major capsid protein p72 (16, 18, 19, 37) , the utility of the inducible gene expression system. We considered it preferable to maintain the target gene in its original site and insert the lac operator downstream of the natural promoter. In this way, we obtained the vA72 recombinant, which contains a hybrid promoter similar to that directing the luciferase expression in vA3, thus allowing high levels of induction.
The essentiality of the protein p72 was demonstrated by the fact that the mutant virus is IPTG dependent. The yield of vA72 under one-step growth conditions in the absence of the inducer was reduced more than 99% compared to that of the parental BA71V. The very few plaques produced by vA72 in these conditions, which were similar in size to those observed in the presence of IPTG, were most likely produced by lacI repression escape mutants, as has been proposed for conditional-lethal recombinant vaccinia viruses (63) . Small amounts of the protein could be detected in the absence of the inducer, indicating that the repression of p72 was not complete. However, since p72 is a major structural protein, large quantities are presumably needed for normal function, and therefore suppression of most of the synthesis of p72 was sufficient to study its function.
Interestingly, the ultrastructural analysis of replication areas of vA72-infected cells revealed that repression of protein p72 synthesis gives rise to accumulation of either single or double zipper-like structures. Both types of viral intermediates consist of pairs of parallel viral envelopes bound by one or two protein layers structurally similar to the core shell of the virion (4-6).
Synthesis of p72 leads to the progressive building of the capsid on the external surfaces of normal viral envelopes as well as zipper-like structures, which became polyhedral forms. Consistent with this, antibodies to p72 labeled the external surfaces of intracellular virus particles. In this context, Cobbold et al. (19) have recently suggested that p72 is externally and internally located in the intracellular virus, likely bound to both faces of an endoplasmic reticulum cisterna which is incorporated by wrapping to the virus structure. Such double localization was proposed from trypsin protection assays in which most of the membrane-associated p72 was resistant to the protease. Our ultrastructural and immunocytochemical analyses argue in favor of an exclusively external location of both the capsid layer and protein p72 in the intracellular particles.
Interestingly, the thickness of the capsid, about 7 nm, was found to be similar to that of iridoviruses, approximately 6 to 9 nm (7, 23, 54) , but in some conflict with the 13 nm previously reported for ASFV capsomers (15) . Thus, our data strengthen the similarities observed between ASFV and iridoviruses in virus shape (15) , capsid protein sequences (38, 49) , and capsomeric disposition in a closely packed hexagonal array (20, 23, 59, 60) .
Very little is known about the mechanism of virion assembly and the protein interactions involved in this process (4, 19, 41) . Most probably, the correct assembly pathway requires the temporally regulated presence of all the needed factors in the replication area. In relation to this, the absence of a major structural component of the capsid in vA72-infected cells under nonpermissive conditions likely explains the accumulation of zipper-like structures. The fine analysis of viral intermediates suggested that a certain proportion of the mature virions could be obtained after IPTG addition from double structures, which were rarely found in normal infections. Therefore, these membranous structures may be aberrant forms which would switch to normal ASFV assembly, constituting an alternative morphogenesis pathway originating as a consequence of capsid formation inhibition. In this sense, it has been reported that different agents can induce aberrant structures during the assembly of viruses. Thus, the drug rifampin prevents the formation of vaccinia virus particles and causes the appearance of characteristic inclusion bodies in the cytoplasm of infected cells. The block can be rapidly reversed by removal of the drug, allowing the assembly of normal vaccinia virus (40, 63) .
On the other hand, a subpopulation of ASFV particles with two inner envelopes, some of them with an electron-dense central nucleoid, was observed after induction, most probably developed by capsid acquisition on single zipper-like structures (5, 6) . Further experiments must be undertaken in order to determine whether these virions are infectious or not.
In conclusion, we have demonstrated that the E. coli lac operator-repressor system provides a powerful tool for studying the role of ASFV genes involved in the virus assembly, making it possible to correlate molecular with morphogenetic events. Similarly, conditional expression of virus genes would allow for the understanding of transcriptional regulation mechanisms, as well as the molecular interactions involved in the virus-host relationship, such as virus infectivity or immune response modulation. Extension of inducible expression to additional ASFV genes is in progress.
